Omega 3 Super Krill Oil
Natural health product licensed in Canada
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80042127
- Status
- Inactive licence
- Licence date
- 6 May 2013
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Euphausia superba Source : En entier Potency : 90 mg Docosahexaenoic acid | 1,000 mg | Not calculated |
| Euphausia superba Source : En entier Potency : 420 mg Phospholipids | Not specified | Not calculated |
| Euphausia superba Source : En entier Potency : 1 mg Esterified astaxanthin | Not specified | Not calculated |
| Euphausia superba Source : En entier Potency : 150 mg Eicosapentaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 9 years ; maximum: 17 years | 1 Capsule | 1 Tous les jours |
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
| Enfants | minimum: 5 years | 1 Capsule | 1 Tous les jours |
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of omega-3 fatty acids for the maintenance of good health. Source of EPA and DHA for the maintenance of good health. Helps to relieve symptoms of dysmenorrheal and premenstrual syndrome. Helps to relieve symptoms of premenstrual syndrome. Helps to maintain cardiovascular health. Helps to reduce serum triglycerides/triacylglycerols in conjunction with conventional statin therapy. Helps to reduce the levels of LDL cholesterol in conjunction with conventional statin therapy. Helps to increase the levels of HDL cholesterol in conjunction with conventional statin therapy. Helps to reduce pain associated with osteoarthritis. Helps to reduce C reactive protein levels, a clinical marker of inflammation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are allergic to shellfish.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are having coagulopathy problems or taking anticoagulants or other medications.
Source
Official Health Canada record, licence 80042127
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.